Table 2.
Distribution of RA patients by health, clinical characteristics at baseline, and gnder.
| Characteristic | N (%) | Females | Males | P-value | |
|---|---|---|---|---|---|
| Health profile | Comorbidities | ||||
| Cardiac diseases | 60 (30.8%) | 45 (28%) | 15 (40.5%) | 0.15 | |
| Hypertension | 48 (24.6%) | 38 (24%) | 10 (27%) | 0.7 | |
| Dyslipidaemia | 23 (11.8%) | 15 (9.5%) | 8 (21.6%) | 0.04 | |
| Diabetes | 18 (9.2%) | 10 (6.3%) | 8 (21.6%) | 0.004 | |
| Depression | 14 (7.2%) | 13 (8.2%) | 1 (2.7%) | 0.24 | |
| Hypothyroidism | 12 (6.2%) | 10 (6.3%) | 2 (5.4%) | 0.83 | |
| Smoking | 57 (29.2%) | 40 (25.3%) | 17 (45.9%) | 0.013 | |
| Alcohol consumption | 30 (15.4%) | 18 (11.4%) | 12 (32.4%) | 0.001 | |
| Clinical Profile | Age at diagnosis (mean + SD) | 44.1 ± 16 | 44.78+15.9 | 40.79+16.8 | 0.22 |
| Years since diagnosis (mean + SD) | 11.3 ± 7 | 10.54 + 7 | 15.6 + 9.6 | 0.001 | |
| DAS28 Score (mean + SD) | 3.82 + 2.27 | 3.4 + 2.3 | 0.42 | ||
| DAS 28 categorized | |||||
| Disease remission (< 2.6) | 46 (26.4%) | 36 (25.5%) | 10 (30.3%) | ||
| Low disease activity (2.6 – 3.2) | 8 (4.6%) | 5 (3.5%) | 3 (9.1%) | ||
| Moderate disease activity (3.2 – 5.1) | 64 (36.8%) | 52 (36.9%) | 12 (36.4%) | ||
| Severe disease activity (> 5.1) | 56 (32.2%) | 48 (34%) | 8 (24.2%) | ||
| HAQ Score | 1.02 + 0.84 | 0.61 + 0.7 | 0.022 | ||
| HAQ categorized | |||||
| Mild to moderate disability (0–1) | 110 (56.4%) | 82 (51.9%) | 28 (75.7%) | ||
| Moderate to severe disability (1–2) | 63 (32.3%) | 55 (34.8%) | 8 (21.6%) | ||
| Severe to very severe disability (2–3) | 22 (11.3%) | 21 (13.3%) | 1 (2.7%) | ||
| Treatment at baseline | |||||
| MTX | 89 (45.6%) | 74 (46.8%) | 15 (40.5%) | 0.48 | |
| DMARDs | 31 (15.9%) | 25 (15.8%) | 6 (16.2%) | 0.95 | |
| Biologics | 18 (9.2%) | 14 (8.9%) | 4 (10.8%) | 0.71 |